- New EASD guidance recommends checking diabetes distress at least annually.
- It says emotional wellbeing should be considered alongside metabolic and clinical measures.
- For adults with type 1 diabetes, CGM and automated insulin delivery may modestly reduce diabetes distress.
Living with diabetes means making decisions about food, glucose, medication, exercise and health every day.
New guidance argues that the emotional burden of doing that should be treated as part of diabetes care rather than an optional extra.
The European Association for the Study of Diabetes has published an evidence-based guideline specifically focused on diabetes distress in adults with type 1 and type 2 diabetes.
Diabetes distress is different from clinical depression.
It describes the frustration, worry, guilt, exhaustion or sense of being overwhelmed that can come from living with and managing diabetes.
The guideline recommends that healthcare professionals ask about it using open questions about the challenges and emotional burden of living with the condition.
Crucially, the authors say diabetes distress should be assessed at least once a year.
It should also be considered during major life events, the development of complications and significant treatment changes.
That puts emotional health much closer to HbA1c, blood pressure and cholesterol in the routine diabetes conversation.
For adults with type 1 diabetes, the guideline conditionally recommends psychological interventions, continuous glucose monitoring and automated insulin delivery as approaches that may reduce distress.
CGM had a small but measurable effect on diabetes distress compared with finger-prick monitoring in six randomised trials.
Automated insulin delivery also tended to improve distress, although the effect was smaller and borderline statistically significant.
For type 2 diabetes, psychological, psychoeducational and educational approaches received conditional recommendations.
That word — conditional — matters.
The quality of evidence varies substantially, and for several psychological interventions it remains low or very low.
This is therefore not evidence that one particular therapy works for everyone.
It is stronger evidence for something more basic: diabetes distress deserves to be recognised, asked about and acted on.
For the UK, this is European guidance rather than a new NICE requirement.
But its recommendations fit naturally into annual diabetes reviews.
There is little value in telling someone their HbA1c needs to improve without also understanding whether diabetes has become exhausting, frightening or simply too difficult to manage.
Guideline link: Read the 2026 EASD diabetes distress guideline in Diabetologia.
